{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:44:23Z","timestamp":1791319463575,"version":"4.3.1"},"reference-count":42,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T00:00:00Z","timestamp":1686787200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoF"],"abstract":"<jats:p>The optimal cut-off value of the optical density index of the galactomannan antigen assays (GM) for diagnosing invasive pulmonary aspergillosis in hematological patients is a disputed topic. This article conducts a systematic review with a meta-analysis to establish which optical density index (ODI) cut-off value should be implemented into clinical practice. Pubmed, Embase and Cochrane databases were searched (N = 27). The pooled data, using a generalized linear mixed model with binomial distribution, resulted in an overall serum sensitivity of 0.76 and a specificity of 0.92. For serum ODI 0.5 there was a pooled sensitivity of 0.92 and a specificity of 0.84. The pooled data of all broncho-alveolar lavage (BAL) studies resulted in an overall sensitivity of 0.80 and a specificity of 0.95. For BAL ODI 0.5, there was a pooled sensitivity of 0.75 and a specificity of 0.88. For the BAL ODI 1.0 pooling, the studies resulted in a sensitivity of 0.75 and a specificity of 0.96. Serum ODI of 0.5 and BAL ODI of 1.0 are the most suitable cut-offs for clinical practice. However, our study affirms that the evidence for the use of GM in clinical practice for the hematological malignancy patient is currently insufficient and more research is needed to determine the diagnostic value of GM.<\/jats:p>","DOI":"10.3390\/jof9060674","type":"journal-article","created":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T03:18:46Z","timestamp":1686799126000},"page":"674","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["The Use of Galactomannan Antigen Assays for the Diagnosis of Invasive Pulmonary Aspergillosis in the Hematological Patient: A Systematic Review and Meta-Analysis"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0456-6928","authenticated-orcid":false,"given":"Lydia M. P.","family":"Bukkems","sequence":"first","affiliation":[{"name":"Maxima Medical Centre, De Run 46000, 5504 DB Veldhoven, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"van Dommelen","sequence":"additional","affiliation":[{"name":"Ziekenhuis Gelderse Vallei, Willy Brandtlaan 10, 6716 RP Ede, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Regis","sequence":"additional","affiliation":[{"name":"Mathematics and Computer Science, Eindhoven University of Technology, Building Helix, Postbus 513, 5600 MB Eindhoven, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin","family":"van den Heuvel","sequence":"additional","affiliation":[{"name":"Mathematics and Computer Science, Eindhoven University of Technology, Building Helix, Postbus 513, 5600 MB Eindhoven, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurens","family":"Nieuwenhuizen","sequence":"additional","affiliation":[{"name":"Maxima Medical Centre, De Run 46000, 5504 DB Veldhoven, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,6,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Sabino, R., Gon\u00e7alves, P., Melo, A.M., Sim\u00f5es, D., Oliveira, M., Francisco, M., Viegas, C., Carvalho, D., Martins, C., and Ferreira, T. (2021). Trends on Aspergillus Epidemiology\u2014Perspectives from a National Reference Laboratory Surveillance Program. J. Fungi, 7.","DOI":"10.3390\/jof7010028"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jinf.2013.04.020","article-title":"Prevention and diagnosis of invasive fungal disease in high-risk patients within an integrative care pathway","volume":"67","author":"Barnes","year":"2013","journal-title":"J. Infect."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1007\/s00134-019-05789-6","article-title":"Invasive pulmonary aspergillosis in critically ill patients with hematological malignancies","volume":"45","author":"Pardo","year":"2019","journal-title":"Intensive Care Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1086\/510592","article-title":"Invasive Aspergillosis following HCT \u2022 CID","volume":"44","author":"Upton","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"5424","DOI":"10.1128\/iai.62.12.5424-5433.1994","article-title":"Chemical and Immunological Characterization of the Extracellular Galactomannan of Asperillus fumigatust","volume":"62","author":"Latge","year":"1994","journal-title":"Infect. Immun."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","article-title":"Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group","volume":"46","author":"Walsh","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"ref_8","unstructured":"Meis, J.F.G., Lashof, A.M.L., Oude Van De Veerdonk, F.L., Br\u00fcggemann, R.J.M., and Dutch Working Party on Antibiotic Policy SWAB Guidelines for the Management of Invasive Fungal Infections Revised version (2022, July 20). 2017-12-14. 86. Available online: swab.nl."},{"key":"ref_9","first-page":"CD012399","article-title":"Galactomannan detection in broncho-alveolar lavage fluid for invasive aspergillosis in immunocompromised patients","volume":"5","author":"Gerritsen","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.micpath.2018.03.059","article-title":"Serum galactomannan for diagnosing invasive aspergillosis in pediatric patients: A meta-analysis","volume":"118","author":"Tong","year":"2018","journal-title":"Microb. Pathog."},{"key":"ref_11","first-page":"CD007394","article-title":"Galactomannan detection for invasive aspergillosis in immunocompromised patients","volume":"2017","author":"Leeflang","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3163\/1536-5050.104.3.014","article-title":"De-duplication of database search results for systematic reviews in EndNote","volume":"104","author":"Bramer","year":"2016","journal-title":"J. Med. Libr. Assoc."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan\u2014A web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst. Rev."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.jclinepi.2003.12.019","article-title":"Empirical Bayes estimates generated in a hierarchical summary ROC analysis agreed closely with those of a full Bayesian analysis","volume":"57","author":"Macaskill","year":"2004","journal-title":"J. Clin. Epidemiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1002\/sim.942","article-title":"A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations","volume":"20","author":"Rutter","year":"2001","journal-title":"Stat. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/myc.12322","article-title":"Potential of polymerase chain reaction and galactomannan for the diagnosis of invasive aspergillosis in patients with febrile neutropenia","volume":"58","author":"Aslan","year":"2015","journal-title":"Mycoses"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1046\/j.1365-2141.2003.04308.x","article-title":"Galactomannan detection in computerized tomography-based broncho-alveolar lavage fluid and serum in haematological patients at risk for invasive pulmonary aspergillosis","volume":"121","author":"Becker","year":"2003","journal-title":"Br. J. Haematol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1378\/chest.09-0701","article-title":"Contribution of galactomannan antigen detection in BAL to the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies","volume":"137","author":"Bergeron","year":"2010","journal-title":"Chest"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.cmi.2016.06.021","article-title":"Diagnosis of invasive fungal infections in haematological patients by combined use of galactomannan, 1,3-\u03b2-D-glucan, Aspergillus PCR, multifungal DNA-microarray, and Aspergillus azole resistance PCRs in blood and bronchoalveolar lavage samples: Results of a prospective multicentre study","volume":"22","author":"Boch","year":"2016","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3906\/sag-1408-100","article-title":"Comparison of galactomannan, beta-D-glucan, and aspergillus DNA in sera of high-risk adult patients with hematological malignancies for the diagnosis of invasive aspergillosis","volume":"46","author":"Kazak","year":"2016","journal-title":"Turk. J. Med. Sci."},{"key":"ref_22","first-page":"223","article-title":"Diagnosis of invasive aspergillosis using bronchoalveolar lavage in haematology patients: Influence of bronchoalveolar lavage human DNA content on real-time PCR performance","volume":"28","author":"Decrucq","year":"2008","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/myc.12787","article-title":"Performance of serum (1,3)-\u00df-d-glucan screening for the diagnosis of invasive aspergillosis in neutropenic patients with haematological malignancies","volume":"61","author":"Furfaro","year":"2018","journal-title":"Mycoses"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jinf.2018.05.001","article-title":"Diagnosis of invasive aspergillosis in hematological malignancy patients: Performance of cytokines, Asp LFD, and Aspergillus PCR in same day blood and bronchoalveolar lavage samples","volume":"77","author":"Heldt","year":"2018","journal-title":"J. Infect."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.diagmicrobio.2014.03.020","article-title":"Clinical utility of Aspergillus galactomannan and PCR in bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in patients with haematological malignancies","volume":"79","author":"Heng","year":"2014","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/myc.12704","article-title":"Clinical evaluation of the newly formatted lateral-flow device for invasive pulmonary aspergillosis","volume":"61","author":"Hoenigl","year":"2017","journal-title":"Mycoses"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Hsu, L.-Y., Ding, Y., Phua, J., Koh, L.-P., Chan, D.S., Khoo, K.-L., and Tambyah, P.A. (2010). Galactomannan testing of bronchoalveolar lavage fluid is useful for diagnosis of invasive pulmonary aspergillosis in hematology patients. BMC Infect. Dis., 10.","DOI":"10.1186\/1471-2334-10-44"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3923\/ijp.2013.86.91","article-title":"Detection of galactomannan and (l-3)-\u03b2-D-glucan for early diagnosis of invasive Aspergillosis in hematological cancer patients","volume":"9","author":"Jin","year":"2013","journal-title":"Int. J. Pharmacol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1093\/cid\/ciaa295","article-title":"Prospective evaluation of the turbidimetric \u03b2-D-glucan assay and two lateral flow assays on serum in invasive aspergillosis","volume":"72","author":"Mercier","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e01913-18","DOI":"10.1128\/JCM.01913-18","article-title":"Diagnosing Invasive Pulmonary Aspergillosis in Hematology Patients: A Retrospective Multicenter Evaluation of a Novel Lateral Flow Device","volume":"57","author":"Mercier","year":"2019","journal-title":"J. Clin. Microbiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.bbmt.2010.11.013","article-title":"Galactomannan testing in bronchoalveolar lavage fluid facilitates the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies and stem cell transplant recipients","volume":"17","author":"Nguyen","year":"2011","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1128\/JCM.43.1.299-305.2005","article-title":"Contribution of (1\u21923)-\u03b2-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: A comparison with serial screening for circulating galactomannan","volume":"43","author":"Pazos","year":"2005","journal-title":"J. Clin. Microbiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1128\/JCM.02091-07","article-title":"Contribution of the (1-->3)-beta-D-glucan assay for diagnosis of invasive fungal infections","volume":"46","author":"Persat","year":"2008","journal-title":"J. Clin. Microbiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/bjh.12285","article-title":"Combined real-time PCR and galactomannan surveillance improves diagnosis of invasive aspergillosis in high risk patients with haematological malignancies","volume":"161","author":"Rogers","year":"2013","journal-title":"Br. J. Haematol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.1128\/JCM.41.8.3922-3925.2003","article-title":"Comparison of real-time PCR, conventional PCR, and galactomannan antigen detection by enzyme-linked immunosorbent assay using bronchoalveolar lavage fluid samples from hematology patients for diagnosis of invasive pulmonary aspergillosis","volume":"41","author":"Sanguinetti","year":"2003","journal-title":"J. Clin. Microbiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"3772","DOI":"10.1128\/JCM.01086-08","article-title":"Detection of circulating Aspergillus fumigatus DNA by real-time PCR assay of large serum volumes improves early diagnosis of invasive aspergillosis in high-risk adult patients under hematologic surveillance","volume":"46","author":"Suarez","year":"2008","journal-title":"J. Clin. Microbiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e12953","DOI":"10.1111\/tid.12953","article-title":"Diagnosis of invasive mold diseases in patients with hematological malignancies using Aspergillus, Mucorales, and panfungal PCR in BAL","volume":"20","author":"Affolter","year":"2018","journal-title":"Transpl. Infect. Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1128\/JCM.03189-12","article-title":"Evaluation of real-time PCR, galactomannan enzyme-linked immunosorbent assay (ELISA), and a novel lateral-flow device for diagnosis of invasive aspergillosis","volume":"51","author":"White","year":"2013","journal-title":"J. Clin. Microbiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"672","DOI":"10.3346\/jkms.2007.22.4.672","article-title":"Comparison of the real-time nucleic acid sequence-based amplification (RTi-NASBA) with conventional NASBA, and galactomannan assay for the diagnosis of invasive aspergillosis","volume":"22","author":"Yoo","year":"2007","journal-title":"J. Korean Med. Sci."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1086\/503427","article-title":"Diagnosis of Invasive Aspergillosis Using a Galactomannan Assay: A Meta-Analysis","volume":"42","author":"Pfeiffer","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3109\/1040841X.2013.804033","article-title":"Utility of bronchoalveolar lavage fluid galactomannan alone or in combination with PCR for the diagnosis of invasive aspergillosis in adult hematology patients: A systematic review and meta-analysis","volume":"41","author":"Heng","year":"2015","journal-title":"Crit. Rev. Microbiol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/myc.12765","article-title":"Diagnostic value of serum galactomannan, 1,3 \u03b2-d-glucan, and Aspergillus fumigatus -specific IgA and IgG assays for invasive pulmonary aspergillosis in non-neutropenic patients","volume":"61","author":"Dobias","year":"2018","journal-title":"Mycosis"}],"container-title":["Journal of Fungi"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2309-608X\/9\/6\/674\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:55:19Z","timestamp":1760126119000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2309-608X\/9\/6\/674"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,15]]},"references-count":42,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,6]]}},"alternative-id":["jof9060674"],"URL":"https:\/\/doi.org\/10.3390\/jof9060674","relation":{},"ISSN":["2309-608X"],"issn-type":[{"value":"2309-608X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,15]]}}}